Breast Cancer

Top Story

Opioid use associated with nonadherence to adjuvant endocrine therapy among breast cancer survivors

Opioid use associated with nonadherence to adjuvant endocrine therapy among breast cancer survivors
January 15, 2018
In the Journals Plus

Chemotherapy use declines in early-stage breast cancer

January 14, 2018
The use and recommendation of chemotherapy for women with both node-negative and node-positive early-stage breast cancer has declined in recent years, according to…
In the Journals Plus

Traditional systemic chemotherapy superior to targeted treatment for HER-2-positive breast cancer

January 12, 2018
Patients with HER-2-positive breast cancer appeared more likely to achieve pathologic complete response when treated with traditional neoadjuvant systemic chemotherapy…
FDA News

FDA approves Lynparza, first treatment for BRCA-mutated breast cancer

January 12, 2018
The FDA expanded the indication of olaparib to include patients with germline BRCA-mutated, HER-2-negative metastatic breast cancer who were previously treated with…
More Headlines »
CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Video

Baseball Hall of Famer: Physician’s confidence affects patients

September 26, 2017
More »
Resource Centers
San Antonio Breast Cancer Symposium

San Antonio Breast Cancer Symposium